JP2023510778A5 - - Google Patents
Info
- Publication number
- JP2023510778A5 JP2023510778A5 JP2022542118A JP2022542118A JP2023510778A5 JP 2023510778 A5 JP2023510778 A5 JP 2023510778A5 JP 2022542118 A JP2022542118 A JP 2022542118A JP 2022542118 A JP2022542118 A JP 2022542118A JP 2023510778 A5 JP2023510778 A5 JP 2023510778A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- alkyl groups
- optionally
- membered
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025160231A JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062958876P | 2020-01-09 | 2020-01-09 | |
| US62/958,876 | 2020-01-09 | ||
| PCT/US2021/012282 WO2021141969A1 (en) | 2020-01-09 | 2021-01-06 | Nanomaterials |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025160231A Division JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023510778A JP2023510778A (ja) | 2023-03-15 |
| JP2023510778A5 true JP2023510778A5 (cg-RX-API-DMAC7.html) | 2024-01-17 |
| JP7791822B2 JP7791822B2 (ja) | 2025-12-24 |
Family
ID=76788721
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542118A Active JP7791822B2 (ja) | 2020-01-09 | 2021-01-06 | ナノマテリアル |
| JP2025160231A Pending JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025160231A Pending JP2026016394A (ja) | 2020-01-09 | 2025-09-26 | ナノマテリアル |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12435035B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4103542A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7791822B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220123536A (cg-RX-API-DMAC7.html) |
| CN (2) | CN115175894B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021205837A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112022013599A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3163161A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL294318A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2022008455A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021141969A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7600208B2 (ja) | 2019-07-29 | 2024-12-16 | ジョージア テック リサーチ コーポレイション | 拘束された脂質を含むナノ材料およびその使用 |
| CN115175894B (zh) | 2020-01-09 | 2024-09-06 | 盖德治疗有限责任公司 | 纳米材料 |
| JP2023534267A (ja) | 2020-07-15 | 2023-08-08 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | ろ材を再生し、煙道ガスを洗浄する方法 |
| WO2022060871A1 (en) | 2020-09-15 | 2022-03-24 | Verve Therapeutics, Inc. | Lipid formulations for gene editing |
| MX2023004371A (es) | 2020-10-14 | 2023-07-26 | George Mason Res Foundation Inc | Lípidos ionizables, y métodos de fabricación y uso de los mismos. |
| JP2024508347A (ja) * | 2020-12-21 | 2024-02-27 | ビーム セラピューティクス インク. | エステル結合アセタールを含むナノ材料 |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| EP4281080A4 (en) * | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| WO2022168884A1 (ja) * | 2021-02-04 | 2022-08-11 | 塩野義製薬株式会社 | カチオン性脂質 |
| JP7883580B2 (ja) * | 2021-10-08 | 2026-07-01 | スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド | 脂質化合物及び脂質ナノ粒子組成物 |
| JP2025504430A (ja) * | 2022-01-17 | 2025-02-12 | サノフイ | 脂質化合物及びその使用 |
| CN117105737B (zh) * | 2022-05-16 | 2026-05-01 | 四川大学 | 一种基于烯烃氢羧基化合成烷基羧酸类化合物的方法 |
| WO2023230601A1 (en) | 2022-05-27 | 2023-11-30 | Beam Therapeutics Inc. | Identification of nanoparticles for preferential tissue or cell targeting |
| EP4540222A1 (en) | 2022-07-20 | 2025-04-23 | Beam Therapeutics Inc. | Nanomaterials comprising triols |
| WO2024199282A1 (zh) * | 2023-03-28 | 2024-10-03 | 苏州艾博生物科技有限公司 | 脂质化合物和脂质纳米颗粒组合物 |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2025038864A1 (en) * | 2023-08-16 | 2025-02-20 | Beam Therapeutics Inc. | Ionizable lipids with linear head groups |
| CN119490447A (zh) * | 2023-08-17 | 2025-02-21 | 苏州星核迪赛生物技术有限公司 | 药物递送材料及其应用 |
| WO2025166314A1 (en) * | 2024-02-02 | 2025-08-07 | Tessera Therapeutics, Inc. | Ex vivo delivery of lipid nanoparticles for delivery of gene modifying systems to t cells |
| WO2025212851A2 (en) | 2024-04-03 | 2025-10-09 | Orbital Therapeutics, Inc. | mRNA COMPOSITIONS AND USES THEREOF IN VARICELLA ZOSTER VIRUS VACCINES |
| WO2025259931A1 (en) | 2024-06-14 | 2025-12-18 | Orbital Therapeutics, Inc. | Compositions and methods for rna circularization |
| WO2026006203A2 (en) | 2024-06-24 | 2026-01-02 | Orbital Therapeutics, Inc. | Compositions and methods for making circular rna |
| WO2026003582A2 (en) | 2024-06-27 | 2026-01-02 | Axelyf ehf. | Lipids and lipid nanoparticles |
| WO2026006687A1 (en) | 2024-06-28 | 2026-01-02 | Orbital Therapeutics, Inc. | Circular rna compositions and uses thereof for diseases caused by varicella-zoster virus |
Family Cites Families (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL257307A (cg-RX-API-DMAC7.html) | 1959-10-28 | |||
| US3686238A (en) | 1970-01-19 | 1972-08-22 | Syntex Corp | Glycerol esterified with 2-naphthyl-acetic acids and fatty acids |
| EP1021549A2 (en) | 1997-09-19 | 2000-07-26 | Sequitur, Inc. | SENSE mRNA THERAPY |
| EP1164125A4 (en) | 1999-11-08 | 2005-05-04 | Daicel Chem | ADAMANTANE DERIVATIVES AND PROCESS FOR PREPARING |
| CN100523215C (zh) | 2000-12-01 | 2009-08-05 | 马普科技促进协会 | 介导rna干涉的小rna分子 |
| WO2003101952A2 (en) | 2002-05-31 | 2003-12-11 | The Regents Of The University Of California | Polyamine-mediated transfection |
| JP2005181734A (ja) | 2003-12-19 | 2005-07-07 | Fuji Photo Film Co Ltd | 画像記録材料 |
| DE102007029471A1 (de) | 2007-06-20 | 2008-12-24 | Novosom Ag | Neue fakultativ kationische Sterole |
| EP2279254B1 (en) | 2008-04-15 | 2017-07-05 | Protiva Biotherapeutics Inc. | Novel lipid formulations for nucleic acid delivery |
| EP4481047A3 (en) | 2010-06-03 | 2025-04-16 | Alnylam Pharmaceuticals, Inc. | Biodegradable lipids for the delivery of active agents |
| US9512073B2 (en) | 2011-10-27 | 2016-12-06 | Massachusetts Institute Of Technology | Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
| DE21212055T1 (de) | 2011-12-07 | 2022-08-04 | Alnylam Pharmaceuticals, Inc. | Biologisch abbaubare lipide zur freisetzung von wirkstoffen |
| ES2887254T3 (es) | 2013-03-08 | 2021-12-22 | Novartis Ag | Lípidos y composiciones lipídicas para el suministro de agentes activos |
| US20150166984A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| US10059655B2 (en) | 2013-12-19 | 2018-08-28 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| US10426737B2 (en) | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| ES2969956T3 (es) | 2014-09-05 | 2024-05-23 | Novartis Ag | Lípidos y composiciones lipídicas para el suministro de agentes activos |
| WO2016187531A1 (en) | 2015-05-21 | 2016-11-24 | Ohio State Innovation Foundation | Benzene-1,3,5-tricarboxamide derivatives and uses thereof |
| HRP20220156T1 (hr) | 2015-09-17 | 2022-04-15 | Modernatx, Inc. | Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| CN108368028B (zh) * | 2015-10-28 | 2021-09-03 | 爱康泰生治疗公司 | 用于递送核酸的新型脂质和脂质纳米颗粒制剂 |
| ES3030658T3 (en) | 2016-03-30 | 2025-07-01 | Intellia Therapeutics Inc | Lipid nanoparticle formulations for crispr/cas components |
| EP4303228B1 (en) | 2016-07-11 | 2026-05-27 | OPKO Biologics Ltd. | Long-acting coagulation factor vii and methods of producing same |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| RS63953B1 (sr) * | 2017-03-15 | 2023-02-28 | Modernatx Inc | Jedinjenje i kompozicije za intracelularnu isporuku terapeutskih sredstava |
| BR112019025104A2 (pt) | 2017-05-30 | 2020-06-23 | Glaxosmithkline Biologicals S.A. | Método de fabricar um sistema de entrega não viral, sistema de entrega não viral, e, composição |
| KR102710962B1 (ko) | 2017-07-04 | 2024-09-27 | 주식회사 인투셀 | 절단성 링커를 포함하는 화합물 및 이들의 용도 |
| JP7449231B2 (ja) | 2017-10-30 | 2024-03-13 | ジョージア テック リサーチ コーポレーション | 組織送達用材料の多重化解析 |
| US11622942B2 (en) | 2017-11-14 | 2023-04-11 | Ohio State Innovation Foundation | Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereof |
| EP3727362A4 (en) | 2017-12-19 | 2021-10-06 | PureTech LYT, Inc. | MYCOPHENOLIC ACID LIPID PRODRUGS AND THEIR USES |
| CN111542338B (zh) | 2017-12-27 | 2024-06-18 | 武田药品工业株式会社 | 含核酸脂质纳米粒子及其用途 |
| CN112955099B (zh) | 2018-07-27 | 2024-04-26 | 雷森斯医疗有限公司 | 医疗冷却装置和使用其的冷却方法 |
| US20210300962A1 (en) | 2018-08-02 | 2021-09-30 | Puretech Lyt, Inc. | Lipid prodrugs of pregnane neurosteroids and uses thereof |
| JP7436990B2 (ja) | 2018-08-10 | 2024-02-22 | 国立大学法人京都大学 | カチオン性脂質を用いた心筋細胞へのトランスフェクション方法 |
| MX2021003455A (es) | 2018-10-02 | 2021-09-21 | Intellia Therapeutics Inc | Lípidos con amina ionizables. |
| CN119285480A (zh) | 2018-12-05 | 2025-01-10 | 英特利亚治疗股份有限公司 | 改性的胺脂质 |
| EP3911302B1 (en) | 2019-01-17 | 2025-09-10 | Georgia Tech Research Corporation | Drug delivery systems containing oxidized cholesterols |
| ES3025233T3 (en) | 2019-01-24 | 2025-06-06 | Agfa Nv | Radiation curable inkjet inks for interior decoration |
| EP3924479A4 (en) | 2019-02-13 | 2023-01-25 | Beam Therapeutics, Inc. | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING THEM TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE |
| AU2020228662A1 (en) | 2019-02-28 | 2021-09-09 | Monash University | Lipid prodrugs of JAK inhibitors and uses thereof |
| WO2020176856A1 (en) | 2019-02-28 | 2020-09-03 | Puretech Lyt, Inc. | Lipid prodrugs of glucocorticoids and uses thereof |
| WO2020176868A1 (en) | 2019-02-28 | 2020-09-03 | Puretech Lyt, Inc. | Lipid prodrugs of btk inhibitors and uses thereof |
| WO2020219876A1 (en) | 2019-04-25 | 2020-10-29 | Intellia Therapeutics, Inc. | Ionizable amine lipids and lipid nanoparticles |
| US20220233459A1 (en) | 2019-06-05 | 2022-07-28 | Guide Therapeutics, Inc. | Analysis of materials for tissue delivery |
| CA3143865A1 (en) | 2019-06-07 | 2020-12-10 | Fujifilm Corporation | Lipid composition |
| JP7600208B2 (ja) | 2019-07-29 | 2024-12-16 | ジョージア テック リサーチ コーポレイション | 拘束された脂質を含むナノ材料およびその使用 |
| EP4004207A4 (en) | 2019-07-29 | 2023-08-23 | Georgia Tech Research Corporation | OLIGONUCLEOTIDE ANTAGONISTS FOR RNA-GUIDED GENO EDITING |
| JP2022552724A (ja) | 2019-10-21 | 2022-12-19 | フラスクワークス, エルエルシー | 細胞培養のためのシステムおよび方法 |
| JP7699128B2 (ja) | 2019-12-06 | 2025-06-26 | ガイド セラピューティクス,エルエルシー | ナノマテリアル |
| CN115175894B (zh) | 2020-01-09 | 2024-09-06 | 盖德治疗有限责任公司 | 纳米材料 |
| JP2024505327A (ja) | 2020-12-21 | 2024-02-06 | ビーム セラピューティクス インク. | 炭酸塩を含むナノ材料 |
| JP2024508347A (ja) | 2020-12-21 | 2024-02-27 | ビーム セラピューティクス インク. | エステル結合アセタールを含むナノ材料 |
| EP4262817A4 (en) | 2020-12-21 | 2025-03-12 | Beam Therapeutics Inc. | NANOMATERIALS WITH ACETALS |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| CA3203741A1 (en) | 2021-01-20 | 2022-07-28 | Beam Therapeutics Inc. | Nanomaterials comprising an ionizable lipid |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| AU2022210299A1 (en) | 2021-01-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable lipids for nanomaterials |
| WO2022251665A1 (en) | 2021-05-28 | 2022-12-01 | Renagade Therapeutics Management Inc. | Lipid nanoparticles and methods of use thereof |
| JP7883580B2 (ja) | 2021-10-08 | 2026-07-01 | スージョウ・アボジェン・バイオサイエンシズ・カンパニー・リミテッド | 脂質化合物及び脂質ナノ粒子組成物 |
| WO2023121971A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Nanomaterials comprising tetravalent lipid compounds |
| WO2023121964A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Nanomaterials comprising disulfides |
| WO2023121965A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Nanomaterial comprising diamines |
| WO2023121970A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable amine and ester lipids and lipid nanoparticles |
| CA3241488A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable amine lipids and lipid nanoparticles |
| EP4540222A1 (en) | 2022-07-20 | 2025-04-23 | Beam Therapeutics Inc. | Nanomaterials comprising triols |
-
2021
- 2021-01-06 CN CN202180016840.5A patent/CN115175894B/zh active Active
- 2021-01-06 MX MX2022008455A patent/MX2022008455A/es unknown
- 2021-01-06 EP EP21738179.7A patent/EP4103542A4/en active Pending
- 2021-01-06 WO PCT/US2021/012282 patent/WO2021141969A1/en not_active Ceased
- 2021-01-06 CA CA3163161A patent/CA3163161A1/en active Pending
- 2021-01-06 JP JP2022542118A patent/JP7791822B2/ja active Active
- 2021-01-06 AU AU2021205837A patent/AU2021205837A1/en not_active Abandoned
- 2021-01-06 IL IL294318A patent/IL294318A/en unknown
- 2021-01-06 KR KR1020227026151A patent/KR20220123536A/ko not_active Ceased
- 2021-01-06 CN CN202411119983.0A patent/CN119684140A/zh active Pending
- 2021-01-06 US US17/142,595 patent/US12435035B2/en active Active
- 2021-01-06 BR BR112022013599A patent/BR112022013599A2/pt unknown
-
2025
- 2025-09-03 US US19/317,946 patent/US20260001838A1/en active Pending
- 2025-09-26 JP JP2025160231A patent/JP2026016394A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023505316A5 (cg-RX-API-DMAC7.html) | ||
| JP2025181861A5 (cg-RX-API-DMAC7.html) | ||
| AU2023200568C1 (en) | Novel lipids and compositions for the delivery of therapeutics | |
| CA2767129C (en) | Compositions and methods for silencing apolipoprotein b | |
| CN104004018B (zh) | 具有含氮脂环式骨架的单链核酸分子 | |
| CN111343994B (zh) | 用于抑制血管生成素-样3 (ANGPTL3)的表达的RNAi剂和组合物以及使用方法 | |
| ES3017428T3 (en) | Ionizable cationic lipids for lipid nanoparticles | |
| AU2022268351A1 (en) | Di-aliphatic substituted pegylated lipids | |
| JP7748500B2 (ja) | トリループを含む二本鎖核酸インヒビター分子 | |
| AU2008242583B2 (en) | Glycoconjugates of RNA interference agents | |
| CN109562188B (zh) | 与三价糖缀合物连接的核酸 | |
| Nawrot et al. | Chemical and structural diversity of siRNA molecules | |
| JP6422961B2 (ja) | 改善された高効率ナノ粒子型オリゴヌクレオチド構造体およびその製造方法 | |
| JP2019530656A (ja) | 4’−リン酸アナログ及びそれを含むオリゴヌクレオチド | |
| JP2022528840A5 (cg-RX-API-DMAC7.html) | ||
| RU2020135289A (ru) | Применение ингибиторов fubp1 для лечения инфекции вирусом гепатита в | |
| WO2019074110A1 (ja) | 一本鎖核酸分子およびその製造方法 | |
| KR20220004675A (ko) | 단축 센스 가닥을 갖는 이중 가닥 핵산 억제제 분자 | |
| KR20260042246A (ko) | 다가 카고 함유 복합체 및 이의 용도 | |
| JP2024508780A5 (cg-RX-API-DMAC7.html) | ||
| JP2024509906A5 (cg-RX-API-DMAC7.html) | ||
| TWI871840B (zh) | 合成4'-磷酸鹽類似物核苷酸亞磷醯胺之方法 | |
| RU2026104839A (ru) | Мультивалентные комплексы, несущие полезную нагрузку, и их применение | |
| RU2020118025A (ru) | Нуклеиновая кислота, композиция и конъюгат, содержащие ее, а также способ их получения и применения | |
| JP2025517341A5 (cg-RX-API-DMAC7.html) |